Immix Biopharma Stock (NASDAQ: IMMX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 15.00 / 147.54K |
Day Range | - - - |
52 Wk Range | 1.74 - 7.75 |
Market Cap | $49.41M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 3.77% |
Days to Cover | 2.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immix Biopharma (NASDAQ:IMMX) through any online brokerage.
Other companies in Immix Biopharma’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR) and OncoCyte (NASDAQ:OCX).
Immix Biopharma has a consensus price target of $10.50.
The stock price for Immix Biopharma (NASDAQ: IMMX) is $1.8 last updated September 20, 2024 at 4:17 PM EDT.
There are no upcoming dividends for Immix Biopharma.
Immix Biopharma’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Immix Biopharma.
Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.